{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:13:51Z","timestamp":1790435631654,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T00:00:00Z","timestamp":1446768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T00:00:00Z","timestamp":1446768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Geographical expansion and re-emerging new genotypes of the Japanese encephalitis virus (JEV) require the development of novel therapeutic approaches. Here, we studied a non-conventional approach for antibody therapy and show that, upon exposure to heme, a fraction of natural human immunoglobulins acquires high-affinity reactivity with the antigenic domain-III of JEV E glycoprotein. These JEV-reactive antibodies exhibited neutralizing activity against recently dominant JEV genotypes. This study opens new therapeutic options for Japanese encephalitis.<\/jats:p>","DOI":"10.1038\/srep16248","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T10:02:01Z","timestamp":1446804121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody"],"prefix":"10.1038","volume":"5","author":[{"given":"Nimesh","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissanne","family":"de Wispelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Lecerf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Scheel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhanshu","family":"Vrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Berek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas V.","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Despr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lacroix-Desmazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan D.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,6]]},"reference":[{"key":"BFsrep16248_CR1","doi-asserted-by":"publisher","first-page":"e2411","DOI":"10.1371\/journal.pntd.0002411","volume":"7","author":"AJ Schuh","year":"2013","unstructured":"Schuh, A. J., Ward, M. J., Brown, A. J. & Barrett, A. D. Phylogeography of Japanese encephalitis virus: genotype is associated with climate. PLoS Negl. Trop. Dis. 7, e2411 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFsrep16248_CR2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2471\/BLT.10.085233","volume":"89","author":"GL Campbell","year":"2011","unstructured":"Campbell, G. L. et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organ. 89, 766\u2013774, (2011).","journal-title":"Bull. World Health Organ."},{"key":"BFsrep16248_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.antiviral.2007.10.005","volume":"78","author":"EA Gould","year":"2008","unstructured":"Gould, E. A., Solomon, T. & Mackenzie, J. S. Does antiviral therapy have a role in the control of Japanese encephalitis? Antiviral Res. 78, 140\u2013149, d (2008).","journal-title":"Antiviral Res."},{"key":"BFsrep16248_CR4","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1128\/JVI.02611-10","volume":"85","author":"M Larena","year":"2011","unstructured":"Larena, M., Regner, M., Lee, E. & Lobigs, M. Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis. J. Virol. 85, 5446\u20135455 (2011).","journal-title":"J. Virol."},{"key":"BFsrep16248_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0035-9203(02)90294-4","volume":"96","author":"DH Libraty","year":"2002","unstructured":"Libraty, D. H. et al. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans. R. Soc. Trop. Med. Hyg. 96, 173\u2013178 (2002).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFsrep16248_CR6","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","volume":"141","author":"J Kimura-Kuroda","year":"1988","unstructured":"Kimura-Kuroda, J. & Yasui, K. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 141, 3606\u20133610 (1988).","journal-title":"J. Immunol."},{"key":"BFsrep16248_CR7","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","volume":"22","author":"DW Beasley","year":"2004","unstructured":"Beasley, D. W. et al. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine 22, 3722\u20133726 (2004).","journal-title":"Vaccine"},{"key":"BFsrep16248_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1442-200X.1988.tb02516.x","volume":"30","author":"A Oya","year":"1988","unstructured":"Oya, A. Japanese encephalitis vaccine. Acta Paediatr. Jpn. 30, 175\u2013184 (1988).","journal-title":"Acta Paediatr. Jpn."},{"key":"BFsrep16248_CR9","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1016\/j.vaccine.2011.06.062","volume":"29","author":"Y Van Gessel","year":"2011","unstructured":"Van Gessel, Y. et al. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO((R))) induced neutralizing antibody titers. Vaccine 29, 5925\u20135931 (2011).","journal-title":"Vaccine"},{"key":"BFsrep16248_CR10","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1128\/JVI.00291-08","volume":"82","author":"AP Goncalvez","year":"2008","unstructured":"Goncalvez, A. P. et al. Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo. J. Virol. 82, 7009\u20137021 (2008).","journal-title":"J. Virol."},{"key":"BFsrep16248_CR11","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1086\/509644","volume":"43","author":"P Caramello","year":"2006","unstructured":"Caramello, P. et al. Role of intravenous immunoglobulin administration in Japanese encephalitis. Clin. Infect. Dis. 43, 1620\u20131621 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep16248_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kazatchkine","year":"2001","unstructured":"Kazatchkine, M. D. & Kaveri, S. V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 345, 747\u2013755 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep16248_CR13","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1086\/423328","volume":"190","author":"PM Winter","year":"2004","unstructured":"Winter, P. M. et al. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J. Infect. Dis. 190, 1618\u20131626 (2004).","journal-title":"J. Infect. Dis."},{"key":"BFsrep16248_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-9071(199702)51:2<132::AID-JMV8>3.0.CO;2-8","volume":"51","author":"V Ravi","year":"1997","unstructured":"Ravi, V. et al. Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J. Med. Virol. 51, 132\u2013136 (1997).","journal-title":"J. Med. Virol."},{"key":"BFsrep16248_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jcv.2010.06.009","volume":"49","author":"N Gupta","year":"2010","unstructured":"Gupta, N., Lomash, V. & Rao, P. V. Expression profile of Japanese encephalitis virus induced neuroinflammation and its implication in disease severity. J. Clin. Virol. 49, 4\u201310 (2010).","journal-title":"J. Clin. Virol."},{"key":"BFsrep16248_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1743-422X-8-92","volume":"8","author":"N Gupta","year":"2011","unstructured":"Gupta, N. & Rao, P. V. Transcriptomic profile of host response in Japanese encephalitis virus infection. Virol. J. 8, 92 (2011).","journal-title":"Virol. J."},{"key":"BFsrep16248_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jaut.2005.03.005","volume":"24","author":"JA McIntyre","year":"2005","unstructured":"McIntyre, J. A., Wagenknecht, D. R. & Faulk, W. P. Autoantibodies unmasked by redox reactions. J. Autoimmun. 24, 311\u2013317 (2005).","journal-title":"J. Autoimmun."},{"key":"BFsrep16248_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1074\/jbc.M509190200","volume":"281","author":"JD Dimitrov","year":"2006","unstructured":"Dimitrov, J. D. et al. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J. Biol. Chem. 281, 439\u2013446 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFsrep16248_CR19","doi-asserted-by":"publisher","first-page":"26696","DOI":"10.1074\/jbc.M702751200","volume":"282","author":"JD Dimitrov","year":"2007","unstructured":"Dimitrov, J. D. et al. Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions. J. Biol. Chem. 282, 26696\u201326706 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFsrep16248_CR20","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1021\/bi501507m","volume":"54","author":"M Hadzhieva","year":"2015","unstructured":"Hadzhieva, M. et al. Mechanism and Functional Implications of the Heme-Induced Binding Promiscuity of IgE. Biochemistry 54, 2061\u20132072 (2015).","journal-title":"Biochemistry"},{"key":"BFsrep16248_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clim.2010.10.010","volume":"138","author":"S Pavlovic","year":"2011","unstructured":"Pavlovic, S. et al. Intravenous immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in attenuating autoimmune diabetes. Clin. Immunol. 138, 162\u2013171 (2011).","journal-title":"Clin. Immunol."},{"key":"BFsrep16248_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/art.27767","volume":"63","author":"T Scheel","year":"2011","unstructured":"Scheel, T., Gursche, A., Zacher, J., Haupl, T. & Berek, C. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum. 63, 63\u201372 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFsrep16248_CR23","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1074\/jbc.M114.618124","volume":"290","author":"M Lecerf","year":"2015","unstructured":"Lecerf, M. et al. Prevalence and Gene Characteristics of Antibodies with Cofactor-induced HIV-1 Specificity. J. Biol. Chem. 290, 5203\u20135213 (2015).","journal-title":"J. Biol. Chem."},{"key":"BFsrep16248_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","volume":"196","author":"Alka","year":"2007","unstructured":"Alka, Bharati, K., Malik, Y. P. & Vrati, S. Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice. Med. Microbiol. Immunol. 196, 227\u2013231 (2007).","journal-title":"Med. Microbiol. Immunol."},{"key":"BFsrep16248_CR25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.25038","volume":"127","author":"JA McIntyre","year":"2010","unstructured":"McIntyre, J. A. & Faulk, A. W. Autoantibody potential of cancer therapeutic monoclonal antibodies. Intl. J. Cancer 127, 491\u2013496 (2010).","journal-title":"Intl. J. Cancer"},{"key":"BFsrep16248_CR26","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1128\/JVI.02686-13","volume":"88","author":"AJ Schuh","year":"2014","unstructured":"Schuh, A. J., Ward, M. J., Leigh Brown, A. J. & Barrett, A. D. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. J. Virol. 88, 4522\u20134532 (2014).","journal-title":"J. Virol."},{"key":"BFsrep16248_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","volume":"4","author":"TC Pierson","year":"2008","unstructured":"Pierson, T. C., Fremont, D. H., Kuhn, R. J. & Diamond, M. S. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4, 229\u2013238 (2008).","journal-title":"Cell Host Microbe"},{"key":"BFsrep16248_CR28","unstructured":"Scheel, T. Die B-Zell-Antwort im Synovialgewebe von Patienten mit Rheumatoider Arthritis Doctoral thesis, Humboldt-Universit\u00e4t zu Berlin (2009)."},{"key":"BFsrep16248_CR29","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1128\/JVI.00358-15","volume":"89","author":"M de Wispelaere","year":"2015","unstructured":"de Wispelaere, M., Frenkiel, M. P. & Despres, P. A Japanese Encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: implication of the structural proteins region in virulence. J. Virol. 89, 5862\u20135875 (2015).","journal-title":"J. Virol."},{"key":"BFsrep16248_CR30","doi-asserted-by":"publisher","first-page":"e00157","DOI":"10.1128\/genomeA.00157-12","volume":"1","author":"F Aubry","year":"2013","unstructured":"Aubry, F. et al. Complete Genome of a Genotype I Japanese Encephalitis Virus Isolated from a Patient with Encephalitis in Vientiane, Lao PDR. Genome Announc. 1, e00157\u201312 (2013).","journal-title":"Genome Announc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep16248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16248","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T08:17:11Z","timestamp":1718180231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep16248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]}},"alternative-id":["BFsrep16248"],"URL":"https:\/\/doi.org\/10.1038\/srep16248","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,6]]},"assertion":[{"value":"16 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16248"}}